OK-432 synergizes with IFN-γ to confer dendritic cells with enhanced antitumor immunity. [electronic resource]
Producer: 20141105Description: 263-74 p. digitalISSN:- 1440-1711
- Animals
- Antineoplastic Agents -- pharmacology
- Biomarkers -- metabolism
- Cell Differentiation -- drug effects
- Cell Movement -- drug effects
- Culture Media, Serum-Free
- Cytokines -- biosynthesis
- Dendritic Cells -- drug effects
- Drug Synergism
- Female
- Humans
- Inflammation Mediators -- metabolism
- Interferon-gamma -- pharmacology
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Monocytes -- pathology
- NF-kappa B -- metabolism
- Neoplasms -- immunology
- Picibanil -- pharmacology
- Signal Transduction -- drug effects
- T-Lymphocytes, Cytotoxic -- drug effects
- Th1 Cells -- drug effects
- p38 Mitogen-Activated Protein Kinases -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.